Omnicell, Inc. (OMCL)
NASDAQ: OMCL · Real-Time Price · USD
29.57
-0.37 (-1.24%)
At close: Oct 29, 2025, 4:00 PM EDT
29.57
0.00 (0.00%)
After-hours: Oct 29, 2025, 4:10 PM EDT
Omnicell Revenue
Omnicell had revenue of $290.56M in the quarter ending June 30, 2025, with 4.98% growth. This brings the company's revenue in the last twelve months to $1.15B, up 6.39% year-over-year. In the year 2024, Omnicell had annual revenue of $1.11B, down -3.04%.
Revenue (ttm)
$1.15B
Revenue Growth
+6.39%
P/S Ratio
1.21
Revenue / Employee
$313,223
Employees
3,670
Market Cap
1.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.11B | -34.87M | -3.04% |
| Dec 31, 2023 | 1.15B | -148.84M | -11.48% |
| Dec 31, 2022 | 1.30B | 163.93M | 14.48% |
| Dec 31, 2021 | 1.13B | 239.81M | 26.88% |
| Dec 31, 2020 | 892.21M | -4.82M | -0.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
OMCL News
- 23 days ago - Omnicell to Release Third Quarter 2025 Financial Results on October 30, 2025 - Business Wire
- 2 months ago - Omnicell Appoints Baird Radford as Executive Vice President and Chief Financial Officer - Business Wire
- 3 months ago - Omnicell, Inc. (OMCL) Q2 2025 Earnings Conference Call Transcript - Seeking Alpha
- 3 months ago - Omnicell Q2 Earnings: Market Ignoring The Segments - Seeking Alpha
- 3 months ago - Omnicell Announces Second Quarter 2025 Results - Business Wire
- 3 months ago - Omnicell to Release Second Quarter 2025 Financial Results on July 31, 2025 - Business Wire
- 5 months ago - Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program - Business Wire
- 6 months ago - Omnicell Announces New Products for Perioperative and Clinic Settings - Business Wire